Literature DB >> 11994361

Glycated low density lipoproteins modify platelet properties: a compositional and functional study.

G Ferretti1, R A Rabini, T Bacchetti, A Vignini, E Salvolini, F Ravaglia, G Curatola, L Mazzanti.   

Abstract

The interaction between low density lipoproteins (LDL) and platelets might play a central role in the development of atherosclerosis in diabetes. The aim of the present study was to investigate whether the glycation of LDL is associated with modifications of their physico-chemical and functional properties and to study the action of glycated LDL (glycLDL) on platelets. LDL and platelets were isolated from 15 healthy subjects. The content of thiobarbituric acid-reactive substances and the generalized polarization of the fluorescent probe Laurdan were determined in LDL glycated in vitro. Platelets were incubated with native LDL, GlycLDL, and minimally oxidized LDL, and the following parameters were evaluated: platelet aggregation, nitric oxide production, intracellular Ca(2+) concentrations, Na(+)/K(+)-adenosine triphosphatase (Na(+)/K(+)-ATPase), and Ca(2+)-ATPase activities. GlycLDL showed increased thiobarbituric acid-reactive substance levels, a red shift of the Laurdan emission maximum, and a decrease in generalized polarization, indicating a higher polarity and a reduced molecular order compared with native LDL. GlycLDL caused a significant increase in platelet nitric oxide production, intracellular Ca(2+) concentration, and aggregating response to ADP; an inhibition of the platelet membrane Na(+)/K(+)-ATPase activity; and a stimulation of Ca(2+)-ATPase activity. Minimally oxidized LDL did not cause statistically significant changes in the parameters studied. The present work demonstrates that glycation induces compositional and structural changes in LDL and suggests that an altered interaction between glycLDL and platelets might play a role in the vascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994361     DOI: 10.1210/jcem.87.5.8466

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

1.  Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.

Authors:  Weifei Zhu; Wei Li; Roy L Silverstein
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

2.  LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets.

Authors:  R Colas; A Sassolas; M Guichardant; C Cugnet-Anceau; M Moret; P Moulin; M Lagarde; C Calzada
Journal:  Diabetologia       Date:  2011-08-17       Impact factor: 10.122

3.  Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves.

Authors:  B Andallu; A V Vinay Kumar; N Ch Varadacharyulu
Journal:  Int J Diabetes Dev Ctries       Date:  2009-07

4.  Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic psammomys obesus.

Authors:  Monika Zoltowska; Edgard Delvin; Ehud Ziv; Noel Peretti; Manon Chartré; Emile Levy
Journal:  Lipids       Date:  2004-01       Impact factor: 1.880

5.  Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

Authors:  P Nivoit; N Wiernsperger; P Moulin; M Lagarde; C Renaudin
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

Review 6.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

7.  Effects of different LDL particles on inflammatory molecules in human mesangial cells.

Authors:  E Santini; R Lupi; S Baldi; S Madec; D Chimenti; E Ferrannini; A Solini
Journal:  Diabetologia       Date:  2008-08-28       Impact factor: 10.122

Review 8.  The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease.

Authors:  James J DiNicolantonio; Sean C Lucan; James H O'Keefe
Journal:  Prog Cardiovasc Dis       Date:  2015-11-14       Impact factor: 8.194

Review 9.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

10.  The relationship between levels of von Willebrand factor and mean platelet volume in subjects with isolated impaired fasting glucose.

Authors:  Feyzi Bostan; Erkan Coban
Journal:  Med Sci Monit       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.